Browse Studies — Arctuva

Phase 1

Perioperative Nutritional Optimization in Patients With Critical Limb Ischemia

A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of…

Critical Limb IschemiaMalnutritionNutritional Supplements

Estimated

~$10 – $6,250

Boston Medical CenterNCT03529019

CTA_IIT_CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesi…

Femoral Arterial CalcificationPeripheral Arterial DiseaseClaudication+1 more

Estimated

~$10 – $750

Yale UniversityNCT05145478

Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention

This is a preliminary prospective observational study measuring change in lower extremity temperature in response to revascularization procedure. The main que…

Peripheral Arterial DiseaseCritical Limb IschemiaCritical Lower Limb Ischemia

Estimated

~$10 – $750

University Hospitals Cleveland Medical CenterNCT06544135

Observational

Serranator OCT: Understanding the Mechanism of Action of Serration Angioplasty by Serranator Versus Conventional Balloon Angioplasty for below-the Knee (BTK) Artery Disease Using Optical Coherence Tomography (OCT)

TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.

Critical Limb Ischemia

Estimated

~$10 – $8,750

Cagent Vascular LLCNCT06434194

Phase 3

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the Incidence of Ischemia-Driven Major Amputation, Clinically Driven Target Lesion Revascularization, and Clinically Relevant Target Lesion Occlusion After Revascularization of Lesions Below the Knee in Patients With Symptomatic Rutherford 3-5 Peripheral Artery Disease

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of i…

Peripheral Artery DiseaseCritical Limb Ischemia

Estimated

~$10 – $8,750

Mercator MedSystems, Inc.NCT04433572

Observational

Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

Critical Limb IschemiaChronic Limb-Threatening IschemiaPeripheral Arterial Disease

Estimated

~$10 – $8,750

LimFlow, Inc.NCT05313165